- Researchers have developed a new at-home saliva test for prostate cancer that analyzes genetic variants in DNA.
- A study suggests this test outperforms the current PSA blood test by reducing false positives and identifying more aggressive cancers.
- The saliva test could lead to earlier diagnosis and treatment, potentially saving the NHS millions annually.
- Experts are optimistic but emphasise the need for further trials to confirm its effectiveness across diverse populations.
- While calls for a national prostate cancer screening program exist, some experts argue that more research is also needed before implementation.
IN FULL
